Exponent (EXPO) Proxy filing summary
Event summary combining transcript, slides, and related documents.
Proxy filing summary
20 Apr, 2026Executive summary
The annual meeting will be held virtually on June 4, 2026, with shareholders of record as of April 8, 2026, eligible to vote on key proposals, including director elections, auditor ratification, and executive compensation approval.
Shareholders can vote electronically, by phone, or by mail, and may submit questions in advance or during the meeting.
The Board recommends voting for all six director nominees, ratification of KPMG LLP as auditor, and approval of executive compensation.
Voting matters and shareholder proposals
Proposals include electing six directors for one-year terms, ratifying KPMG LLP as auditor for fiscal 2026, and an advisory vote on 2025 executive compensation.
Majority vote is required for each proposal; abstentions and broker non-votes have no effect on director elections and executive compensation proposals.
Shareholders may submit proposals and director nominations for the 2027 meeting following SEC rules and company bylaws.
Board of directors and corporate governance
Six nominees for the board include experienced leaders from legal, technology, consulting, and academic backgrounds.
A majority of the board is independent per Nasdaq standards; Ms. Richardson will become Chairman after Dr. Johnston retires.
The board held six meetings in 2025, with all directors attending at least 75% of meetings.
Committees include Audit, Human Resources, and Nominating and Governance, all composed of independent directors.
The board separates CEO and Chairman roles and has guidelines for board leadership and risk oversight.
Latest events from Exponent
- Strong Q4 and FY2025 results, with high single-digit growth and margin expansion expected in 2026.EXPO
Q4 202513 Apr 2026 - Q2 2024 net income up 14% on flat revenues, with raised guidance and strong sector demand.EXPO
Q2 20242 Feb 2026 - Q3 net income up 6% to $26M, margin guidance raised, and $0.28 dividend declared.EXPO
Q3 202418 Jan 2026 - Q4 and FY24 results exceeded expectations; 2025 growth to be modest amid headcount recovery.EXPO
Q4 202425 Dec 2025 - Flat Q1 revenue, lower net income, and stable 2025 outlook with rising headcount.EXPO
Q1 202523 Dec 2025 - Shareholders will vote on director elections, auditor ratification, and executive pay, all recommended for approval.EXPO
Proxy Filing1 Dec 2025 - Q2 2025 revenues up 1%, lower margins, strong dispute-related growth, positive outlook.EXPO
Q2 202516 Nov 2025 - Q3 2025 delivered double-digit revenue growth, higher net income, and raised margin guidance.EXPO
Q3 20257 Nov 2025